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CalciumSTIM1 is a transmembrane protein essential for the activation of store-operated Ca2+ entry (SOCE), a major
Ca2+ inﬂux mechanism. STIM1 is either located in the endoplasmic reticulum, communicating the Ca2+
concentration in the stores to plasma membrane channels or in the plasma membrane, where it might sense
the extracellular Ca2+ concentration. Plasma membrane-located STIM1 has been reported to mediate the
SOCE sensitivity to extracellular Ca2+ through its interaction with Orai1. Here we show that plasma
membrane lipid raft domains are essential for the regulation of SOCE by extracellular Ca2+. Treatment of
platelets with the SERCA inhibitor thapsigargin (TG) induced Mn2+ entry, which was inhibited by increasing
concentrations of extracellular Ca2+. Platelet treatment with methyl-β-cyclodextrin, which removes
cholesterol and disrupts the lipid raft domains, impaired the inactivation of Ca2+ entry induced by
extracellular Ca2+. Methyl-β-cyclodextrin also abolished translocation of STIM1 to the plasma membrane
stimulated by treatment with TG and prevented TG-evoked co-immunoprecipitation between plasma
membrane-located STIM1 and the Ca2+ permeable channel Orai1. These ﬁndings suggest that lipid raft
domains are essential for the inactivation of SOCE by extracellular Ca2+ mediated by the interaction between
plasma membrane-located STIM1 and Orai1.y, University of Extremadura,
27257110.
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Store-operated Ca2+ entry (SOCE) is a major mechanism for Ca2+
inﬂux that regulates a number of critical cell functions. SOCE is regulated
by the ﬁlling state of the intracellular Ca2+ stores, although the precise
mechanism regulating its activation/deactivation is not fully under-
stood. There is a large body of evidence supporting that the stromal
interactionmolecule 1 (STIM1), a transmembrane protein located in the
Ca2+ stores, acts as the intraluminal Ca2+ sensor [1,2] that commu-
nicates the amount of stored Ca2+ to plasmamembrane (PM) channels,
including Orai, especially Orai1 protein [3,4], and TRP family members
[5–7]. STIM1 has a single transmembrane region with a N-terminal EF-
hand Ca2+ binding domain that is located in the lumen of the ER. Ca2+
store dischargehas been reported to induce rapid translocationof STIM1
from a diffuse location in the ER membrane into puncta that
accumulated near the PM store-operated channels [8].
In addition to its placement in the ER, STIM1 has been found to be
located in the PM in different cell types [9–11]. This is the case of
human platelets, where STIM1 has been reported to migrate from ER
sites to the PM upon depletion of the Ca2+ store [12], although the
PM-resident pool remains as a minor fraction of the cellular STIM1(Jardin I, personal communication). The role of the PM-spanning
STIM1 is rather unknown; however, the Ca2+ binding EF-hand
domain of PM-resident STIM1 faces the extracellular medium, thus
suggesting that, as for the ER, STIM1 might play a role sensing the
extracellular Ca2+ concentration. In human platelets, we have
recently reported that PM-located STIM1 plays an essential role in
the mechanism of inactivation of SOCE by extracellular Ca2+ [13].
According to this, store-operated divalent cation entry is reduced by
extracellular Ca2+ in a concentration-dependent manner [13],
probably as a mechanism to protect the cell against Ca2+ overload,
which might lead to the development of apoptotic events [14–17]. In
these cells, external application of an antibody that recognizes the EF-
hand domain impairs the sensitivity of SOCE to the extracellular Ca2+
concentration, thus supporting a role for PM-resident STIM1 in SOCE
regulation by extracellular Ca2+, probably through its association
with Orai1 [13].
Cell signaling complexes have been reported to associate to
microdomains that facilitate the interaction between proteins of a
signaling cascade. Lipid rafts are detergent-resistant PM microdo-
mains, enriched in cholesterol and sphingolipids, which serve as
platforms for the recruitment of signaling complexes. Lipid rafts have
been reported to modulate SOCE in different manners, including
clustering STIM1 in ER-PM junctions [18] or facilitating the associa-
tion between STIM1 and TRPC1 [19]. In human platelets, lipid rafts
recruit TRPC1, TRPC4 and TRPC5 in signaling complexes [20,21] and
facilitate the association between STIM1, Orai1 and TRPC1 [22].
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essential for the activation but not the maintenance of SOCE in HEK-
293 cells. Disruption of lipid rafts by MβCD before store depletion
results in attenuation of SOCE and the association between STIM1,
Orai1, TRPC1 and TRPC6; in contrast, when lipid rafts were disrupted
in cells with depleted stores, SOCE, as well as the association between
STIM1, Orai1 and TRPC1 was unaltered, but the association between
Orai1 and TRPC6 was attenuated, leading to the activation of a non-
capacitative Ca2+ entry mechanism [23]. In the present study we have
investigated the role of lipid rafts in the regulation of SOCE by
extracellular Ca2+ through the association between PM-resident
STIM1 and Orai1 in human platelets, which might shed new light on
the molecular basis underlying SOCE.
2. Materials and methods
2.1. Materials
Fura-2 acetoxymethyl ester (fura-2/AM) was from Molecular
Probes (Leiden, the Netherlands). Apyrase (grade VII), aspirin, bovine
serum albumin (BSA), methyl-β-cyclodextrin (MβCD), thapsigargin
(TG), valinomycin, dimethyl BAPTA-AM and paraformaldehyde were
from Sigma (Madrid, Spain). Anti STIM1 (25–139) antibody was from
BD Transduction Laboratories (Frankin Lakes, NJ). Fluorescein-
isothiocyanate (FITC)-conjugated donkey anti-mouse IgG antibody
was from Santa Cruz Biotechnology (Santa Cruz, CA). Cholesterol E
test was from Wako Diagnostics (Richmon, VA). All other reagents
were of analytical grade.
2.2. Platelet preparation
Platelets samples were prepared as described previously [24] in
accordance with the Declaration of Helsinki. Brieﬂy, blood was
obtained from drug-free healthy volunteers and mixed with one-
sixth volume of acid/citrate dextrose anticoagulant containing (in
mM): 85 sodium citrate, 78 citric acid and 111 D-glucose. Platelet-rich
plasma was then prepared by centrifugation for 5 min at 700×g and
aspirin (100 μM) and apyrase (40 μg/ml) added. Platelets were
collected by centrifugation at 350×g for 20 min and resuspended in
HEPES-buffered saline (HBS) containing (in mM): 145 NaCl, 10
HEPES, 10 D-glucose, 5 KCl, 1 MgSO4, pH 7.45 and supplemented with
0.1% w/v BSA and 40 μg/ml apyrase.
2.3. Cell viability
Cell viability was assessed using calcein and trypan blue. For
calcein loading, cells were incubated for 30 min with 5 μM calcein-AM
at 37 °C and centrifuged and the pellet was resuspended in fresh HBS.
Fluorescence was recorded from 2 ml aliquots using a Cary Eclipse
Spectrophotometer (Varian Ltd., Madrid, Spain). Samples were
excited at 494 nm, and the resulting ﬂuorescence was measured at
535 nm. The results obtained with calcein were conﬁrmed using the
trypan blue exclusion technique. Ninety-ﬁve percent of cells were
viable in our platelet preparations, at least during the performance of
the experiments.
2.4. Determination of Mn2+ entry
Mn2+ was used to monitor divalent cation entry. Mn2+ inﬂux was
monitored in 1 ml aliquots of magnetically stirred cellular suspension
(2×108 cells/ml) at 37 °C using a Cary Eclipse Spectrophotometer
(Varian Ltd., Madrid, Spain) as a quenching of fura-2 ﬂuorescence at
the isoemissive wavelength of 360 nm and presented on an arbitrary
linear scale. As previously shown [13], fura-2 ﬂuorescence upon
excitation at 360 nm was Ca2+ insensitive in our platelet prepara-
tions. To compare the rate of decay (slope) of fura-2 ﬂuorescencewhen platelets were subjected to different experimental procedures
traces were ﬁtted to the equation y=Ax+B, where A is the slope and
B is the fura-2 ﬂuorescence at the initiation of the experiment.
2.5. Immunoﬂuorescence
The amount of PM-STIM1 was determined in samples by
immunoﬂuorescence. Brieﬂy, ﬁxed platelets were washed in PBS to
remove the ﬁxative and incubated for 2 h with 1 μg/ml anti-STIM1
(25–139) antibody. The platelets were then collected by centrifuga-
tion and washed twice in PBS. To detect the primary antibody,
samples were incubated with 0.02 μg/ml FITC-conjugated donkey
anti-mouse IgG antibody for 1 h and washed twice in PBS. Fluores-
cence was measured using a spectroﬂuorimeter (Varian Ltd., Madrid,
Spain). Samples were excited at 496 nm, and emission was at 595 nm.
2.6. Immunoprecipitation and Western blotting
The interaction between plasma membrane-located STIM1 and
Orai1 were determined using a previously established procedure [25].
Brieﬂy, cells were stimulated and ﬁxed by incubation with 3% (w/v)
paraformaldehyde in phosphate-buffered saline (PBS) containing (in
mM) 137 NaCl, 2.7 KCl, 5.62 Na2HPO4, 1.09 NaH2PO4, 1.47 KH2PO4, pH
7.2 and supplemented with 0.5% (w/v) BSA, on ice for 10 min. Fixed
platelets were washed in PBS to remove the ﬁxative, incubated for 1 h
with anti-STIM1 (25–139) antibody and thenwashed again to remove
the antibody. Cells were then lysed by incubationwith RIPA buffer, pH
7.2, containing 474 mM NaCl, 30 mM Tris, 3 mM EGTA, 0.3 % SDS, 3%
sodium deoxycholate, 3% triton X-100, 3 mM Na3VO4, 3 mM phenyl-
methylsulfonyl ﬂuoride, 150 μg/ml leupeptin and 15 mM benzami-
dine. Anti-STIM1 (25–139) antibody-bound PM-STIM1 was
immunoprecipitated by addition of 25 μL of protein A–agarose
overnight at 4 °C on a rocking platform. Immunoprecipitation of
STIM1 from whole cell lysates was performed as described previously
[6,26].The immunoprecipitates were resolved by 10% SDS-PAGE and
separated proteins were electrophoretically transferred onto nitro-
cellulose membranes for subsequent probing. Blots were incubated
overnight with 10% (w/v) BSA in Tris-buffered saline with 0.1% Tween
20 (TBST) to block residual protein binding sites. Immunodetection of
Orai1 and STIM1 was achieved using the anti-Orai1 antibody diluted
1:1000 in TBST for 2 h or the anti-STIM1 (25–139) antibody diluted
1:250 in TBST for 2 h. The primary antibody was removed and blots
were washed six times for 5 min each with TBST. To detect the
primary antibody, blots were incubated for 45 min with horseradish
peroxidase-conjugated donkey anti-rabbit IgG antibody or horserad-
ish peroxidase-conjugated ovine anti-mouse IgG antibody, respec-
tively, diluted 1:10,000 in TBST and then exposed to enhanced
chemiluminescence reagents for 4 min. Blots were then exposed to
photographic ﬁlms. The density of bands on the ﬁlm was measured
using a scanning densitometry and ImageJ software.
2.7. Measurement of cholesterol levels
Quantitative determination of total cholesterol was performed
using a previously described procedure [23]. Platelets (108 cells/200
μL PBS) were lysed, and cholesterol was extracted from cell lysates by
adding chloroform (400 μL) and methanol (400 μL) to the sonicated
cell lysate (100 μL). The bottom (chloroform) layer was collected and
evaporated under vacuum, and cholesterol was dissolved in ethanol
and assayed using the colorimetric assay Cholesterol E test, with
absorbance determined at 600 nm in a spectrophotometer.
2.8. Cholesterol-loaded MβCD (CLCD) preparation
CLCD was prepared as described previously [27,28]. Brieﬂy,
100 μmol of MβCD were disolved in 600 μL of methanol and mixed
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followed by high vacuum for at least 1 h and then dispersed in 2 ml of
PBS. The resulting solution was sonicated for 3 min, incubated in a
shaker at 37 °C overnight and ﬁlteredwith a 0.22-μmpore size syringe
ﬁlter.
2.9. Statistical analysis
Analysis of statistical signiﬁcance was performed using Student's
unpaired t-test for parametric variables. For multiple comparisons,
one-way analysis of variance (ANOVA) combined with the Dunnet
tests was used. pb0.05 was considered to be signiﬁcant.
3. Results
3.1. Role of lipid rafts in TG-evoked Mn2+ entry in the presence of
different extracellular concentrations of Ca2+
We have recently described the effect of increasing concentrations
of extracellular Ca2+ on store-operated divalent cation entry by
measuringMn2+ inﬂux [13]. Mn2+ can be used as a surrogate for Ca2+
given its quenching effect on fura-2 ﬂuorescence [29]. In addition,
Mn2+ avoids complications arising from the activation of Ca2+
transport mechanisms, such as the PM Ca2+-ATPase (PMCA) or the
Na+/Ca2+ exchanger, since Mn2+ is transported by PMCA with lower
afﬁnity than Ca2+ [30] and inhibits Na+/Ca2+ exchange [31]. To
prevent interferences in Mn2+ entry attributed to distinct membrane
depolarization due to cells exposure to increasing extracellular Ca2+
concentrations, the experiments were performed in the presence of
the K+ ionophore valinomycin (3 μM), in order to stabilize theFig. 1. TG-evoked Mn2+ entry in the presence of different extracellular concentrations of
incubated for 30 min at 37 °C with DMSO (the vehicle of MβCD). Valinomycin (3 μM) was
3 mM), as indicated, and 500 μM Mn2+ were added. Fura-2 ﬂuorescence was measured at
(Control) or stimulated with TG (200 nM). For Ca2+-free conditions 100 μM EGTA was addplatelet membrane potential close to the K+ equilibrium potential
[32]. As shown in Fig. 1A, in the absence of extracellular Ca2+ (100 μM
EGTA added) treatment of platelets with the speciﬁc inhibitor of the
Ca2+-ATPases of internal stores (SERCAs), TG (200 nM), in the
presence of 500 μM external Mn2+, resulted in a sustained quenching
of fura-2 ﬂuorescence comparedwith non-stimulated cells. The rate of
decay (slope) of fura-2 ﬂuorescence at 360 nm observed in a medium
containing 500 μM Mn2+ in the presence of TG, was signiﬁcantly
reduced in the presence of increasing concentrations of extracellular
Ca2+ (0.3–3 mM) with no detectable effects on fura-2 ﬂuorescence in
the absence of TG (Figs. 1B–D and 3).
We have investigated the role of lipid rafts in TG-evokedMn2+ entry
by preincubation with MβCD, a compound widely used to remove
cholesterol from cells, thus disrupting the lipid raft domains [22,33].
Treatment of human platelets for 30 min with 10 mMMβCD reduced
the cholesterol content by 83±5% as detected by using the colorimetric
assay Cholesterol E test. As shown in Figs. 2 and 3, the quenching of fura-
2 ﬂuorescence at 360 nm after stimulation of TG in the presence of
500 μMMn2+was insensitive to extracellular Ca2+when plateletswere
preincubated for 30 minwith 10 mMMβCD. TG-inducedMn2+ entry in
MβCD-treated cells was signiﬁcantly attenuated at extracellular Ca2+
concentrations of 0 and 0.3 mM as compared to control (not treated
with MβCD) but was signiﬁcantly enhanced in the presence of 3 mM
extracellular Ca2+ (Fig. 3), thus suggesting that lipid raft disruption
impairs the regulation of store-operated divalent cation entry depen-
dent on extracellular Ca2+. MβCD treatment did not affect Mn2+ leak in
the absence of TG (Fig. 2), suggesting that this agent does not affect
plasma membrane permeability to cations.
In order to investigate whether the effects induced by MβCD were
speciﬁc of cholesterol depletion, we repeated the experiments withCa2+. Human platelets were loaded with fura-2 and resuspended in HBS. Cells were
added 5 min before the onset of the experiment. At the time of experiment CaCl2 (0–
the isoemissive excitation wavelength of 360 nm. Platelets were either left untreated
ed to the medium. Traces are representative of six separate experiments.
Fig. 2. Effect of MβCD on TG-evoked Mn2+ entry in the presence of different extracellular concentrations of Ca2+. Human platelets were loaded with fura-2 and resuspended in HBS.
Cells were incubated for 30 min at 37 °C with 10 mMMβCD. Valinomycin (3 μM)was added 5 min before the onset of the experiment. At the time of experiment CaCl2 (0–3 mM), as
indicated, and 500 μM Mn2+ were added. Fura-2 ﬂuorescence was measured at the isoemissive excitation wavelength of 360 nm. Platelets were either left untreated (Control) or
stimulated with TG (200 nM). For Ca2+-free conditions 100 μM EGTA was added to the medium. Traces are representative of six separate experiments.
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abolished the effect of MβCD on TG-evoked Mn2+ entry in the
presence of increasing extracellular concentrations of Ca2+ (Fig. 3),Fig. 3. Effect of MβCD on the slope of TG-evokedMn2+ entry in the presence of different
extracellular concentrations of Ca2+. Human platelets were loaded with fura-2 and
resuspended in HBS. Cells were incubated for 30 min at 37 °C with 10 mMMβCD or
with 10 mM cholesterol-loaded MβCD (CLCD), as indicated. Valinomycin (3 μM) was
added 5 min before the onset of the experiment. At the time of experiment CaCl2 (0–
3 mM), as indicated, and 500 μMMn2+ were added. Fura-2 ﬂuorescence was measured
at the isoemissive excitation wavelength of 360 nm. Platelets were either left untreated
(Control) or stimulated with TG (200 nM). Data indicate the slope of Mn2+ entry traces
in TG-stimulated platelets in the presence of different concentrations of extracellular
Ca2+ expressed as means±SEM ([Ca2+]o=0 mM; 100 μM EGTA added). The rate of
decay (slope) of fura-2 ﬂuorescence due to Mn2+ entry was determined as described in
Materials and methods. Signiﬁcance values indicate differences compared with TG-
treated cells in the absence of MβCD. *pb0.05.which indicates that the effect observed with MβCD was speciﬁc of
cholesterol removal.
3.2. Role of lipid rafts in TG-induced surface expression of STIM1
After Ca2+ store depletion, STIM1 has been reported to migrate to
the PM, where the EF-hand domain faces the extracellular medium and
might act as an extracellular Ca2+ sensor [2,9]. We have previously
reported that treatment with TG results in Ca2+-dependent transloca-
tion of STIM1 to the PM [13]. Hence, we have now investigated the role
of lipid rafts in TG-induced surface expression of STIM1 by immuno-
ﬂuorescence. Human platelets were incubated with 10 mMMβCD for
30 min, and immunoﬂuorescence in restingandTG-stimulated cellswas
determined using the anti-STIM1 (25–139) antibody on the basis of the
N-terminal extracellular location of the STIM1 (25–139) sequence of
PM-resident STIM1. As shown in Fig. 4, incubation of ﬁxed, non-
permeabilized resting platelets in suspension with 1 μg/ml anti-STIM1
(25–139) antibody followed by detection using an FITC-conjugated
secondary antibody revealed the presence of STIM1 proteins in the
cellular surface. Data presented in Fig. 4were correctedby subtraction of
the ﬂuorescence due to non-speciﬁc binding of the secondary antibody
alone, which was less than 20% of the ﬂuorescence detected in the
presence of the anti-STIM1 (25–139) antibody (data not shown). In the
presence of 1 mM extracellular Ca2+, platelet stimulation with TG for
10 s enhanced surface expression of STIM1 by 18% (Fig. 4). After 30 min
preincubation with 10 mMMβCD the effect of TG was abolished
without altering detection of STIM1 in the PM in resting cells (Fig. 4;
pb0.05; n=5). Treatment with CLCD was without effect on the surface
expression of STIM1 both at resting conditions and upon stimulation
with TG, thus suggesting that lipid rafts are necessary for TG-evoked
translocation of STIM1 to the PM.
Fig. 4. Effect of MβCD on TG-induced surface expression of STIM1. Platelets were
incubated for 30 min at 37 °C with 10 mM MβCD or with 10 mM cholesterol-loaded
MβCD (CLCD), as indicated, and then stimulated in the presence of 1 mM Ca2+ with
200 nM TG for 10 s before mixing with an equal volume of ice-cold formaldehyde 3%
(w/v) in PBS for 10 min. Cells were then incubated with 1 μg/ml anti-STIM1 (25–
139) antibody for 2 h followed by incubation with FITC-conjugated anti-mouse IgG
for a further 1 h. Histograms indicate the immunoﬂuorescence values under
different experimental conditions. Values are means±SEM of ﬁve independent
experiments. * pb0.05.
Fig. 5. Effect of MβCD on TG-induced association of plasma membrane STIM1 and Orai1
in human platelets. Platelets were incubated for 30 min at 37 °C with 10 mMMβCD or
with 10 mM cholesterol-loaded MβCD (CLCD), as indicated, and then stimulated with
200 nM TG for 10 s before mixing with an equal volume of ice-cold formaldehyde 3%
(w/v) in PBS for 10 min. Cells were then incubated with 1 μg/ml anti-STIM1 (25–139)
antibody for 2 h, washed twice in PBS and lysed. Whole cell lysates were incubated
overnight with 25 μg/ml agarose beads and immunoprecipitates were subjected to 10%
SDS-PAGE and subsequent Western blotting with a speciﬁc anti-Orai1 antibody.
Membranes were reprobed with the anti-STIM1 (25–139) antibody for protein loading
control. The panel shows results from one experiment representative of ﬁve others.
Molecular masses indicated on the right were determined using molecular-mass
markers run in the same gel. Histograms represent the quantiﬁcation of plasma
membrane STIM1 (PM-STIM1)-Orai1 association in resting (control) and TG-treated
cells. Results are presented as arbitrary optical density units and expressed as means±
S.E.M. *pb0.05 compared to control (cells not stimulated with TG).
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STIM1 and Orai1
Since our previous studies have reported that regulation of SOCE
by extracellular Ca2+ is likely mediated by association of PM-located
STIM1 and Orai1 in human platelets [13], we have now investigated
whether lipid raft domains disruption impairs this regulatory
mechanism by preventing association between these proteins. The
association between PM-resident STIM1 and Orai1 was found
capacitative in nature since it exists in cells heavily loaded with the
intracellular Ca2+ chelator dimethyl BAPTA where the stores were
depleted using TG [13]. We have tested for the association between
PM-STIM1 and Orai1 by looking for co-immunoprecipitation. Platelets
loaded with dimethyl BAPTA were preincubated for 30 min in the
absence and presence of 10 mMMβCD and then stimulated with 200
nM TG for 10 s before mixing with paraformaldehyde (1.5% in PBS).
We have recently reported that ﬁxing with glutaraldehyde provides
similar results [13]. Fixed cells were washed and incubated with anti-
STIM1 (25–139) antibody for 2 h further, washed, and lysed.
Immunoprecipitation in the presence of agarose beads was performed
overnight without further addition of antibodies and subsequent SDS-
PAGE and Western blotting were conducted. As shown in Fig. 5,
treatment for 10 s with TG enhanced the association between PM-
resident STIM1 and Orai1 by 86%. Treatment with 10 mMMβCD for
30 min reduced TG-evoked response by 85% (Fig. 5, top panel and
histogram; pb0.05; n=4), while preincubation, for the same time
and with the same concentration of CLCD did not signiﬁcantly alter
the association between PM-spanning STIM1 and Orai1 (Fig. 5, top
panel and histogram; pb0.05; n=4). Western blotting of the same
membranes with anti-STIM1 (25–139) antibody conﬁrmed a similar
content of this protein in all lanes (Fig. 5, bottom panel).
Wehave further investigated the roleof lipid rafts on theassociationof
Orai1 with STIM1 immunoprecipitated from platelet whole cell lysates,
including both PM-located and intracellular STIM1. Treatment of
dimethyl BAPTA-loaded human platelets for 10 s with 200 nM TG
enhances the association of STIM1 with Orai1 by 267±39% of control
(resting cells). Preincubation of platelets for 30 min with 10 mMMβCD
reduced the association of STIM1 with Orai1 stimulated by TG to 122±
14% of control, without having any effect on the resting association
between these proteins.4. Discussion
SOCE is amechanism regulated by the ﬁlling state of the intracellular
Ca2+ stores that is fully inactivated by Ca2+ store replenishment [34].
Although the activation of SOCE has been extensively investigated, the
mechanisms of SOCE inactivation remain unclear. One of the mecha-
nisms of SOCE inactivation is the fast inactivation of CRAC/Orai channels,
withmillisecond time constants, that arises from feedback inhibition of
ICRAC mediated by the cytosolic Ca2+ concentration around individual
CRAC channels [35,36]. In addition, a role for PM-resident STIM1,
sensing the extracellular Ca2+, in the inactivation of SOCE has also been
reported in different cell types [11], including human platelets [13].
Inactivation of SOCE by PM-spanning STIM1 has been suggested to be
mediated by interaction with Orai1 [13]. A recent study has revealed
that the CRACmodulatory domain, within the amino acids 474 and 485
in the cytosolic region of STIM1, provides a negative feedback signal to
Ca2+ entry by inducing fast Ca2+-dependent inactivation of CRAC/Orai
channels [37]; however, whether the observed SOCE inactivation by
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inactivation of CRAC/Orai channels remains unclear.
Lipid rafts are sphingolipids and cholesterol enriched plasma
membrane domains that function as platforms formembrane proteins
[38]. Lipid rafts recruit speciﬁc set of proteins including those
associated to G protein-coupled receptor signaling or proteins of the
Src family [39]. Lipid rafts have also been shown to contain proteins of
the SOCE pathway, including the TRPC members TRPC1, TRPC4 and
TRPC5 [20,21], Orai1 [40] and STIM1 [18,19] and regulate the mode of
activation of certain Ca2+ permeable channels [19,40]. MβCD has
been extensively used to remove cholesterol from cells and disrupt
lipid rafts [21,41], an experimental maneuvre that signiﬁcantly
attenuates SOCE in different cell types [22,42,43], which might be
attributed to impairment of the association between SOCE proteins.
Our results indicate that disruption of lipid rafts by MβCD attenuates
SOCE, as previously published by us and others, and impairs the
sensitivity of SOCE to extracellular Ca2+, which, to our knowledge, is
the ﬁrst description of a role of lipid rafts in the regulation of SOCE by
the extracellular Ca2+ concentration mediated by STIM1. As a
consequence, at Ca2+ concentrations in the medium as high as
3 mM divalent cation entry induced by TG was signiﬁcantly greater in
the presence of MβCD than in its absence, thus limiting the cellular
ability to protect against cell toxicity. The effect of lipid raft disruption
might be attributed to the impairment of STIM1 localization in the PM
upon treatment with TG and, subsequently, association with the Ca2+
channel Orai1. Although, since the store depletion-induced associa-
tion of PM-spanning STIM1 with Orai1 is much greater than PM
association of STIM1, we cannot rule out the possibility that
impairment of the association between PM-STIM1 and Orai1 is due
to changes in the lipid environment rather than to impairment of PM
association of STIM1. Nevertheless, lipid raft disruption did not alter
the resting level of either expression of STIM1 in the plasma
membrane or co-immunoprecipitation of PM-spanning STIM1 with
Orai1. Although the reason of this phenomenon has not been further
investigated, it might be explained either by the presence of both lipid
raft-dependent and -independent STIM1 pools in the PM or to a
reduced turnover of both events.
Our results indicate that lipid raft domains are necessary for the
association of Orai1, not only with PM-resident STIM1, but also with
the intracellular pool of STIM1, as detected by immunoprecipitation of
whole cell lysates with anti-STIM1 antibody followed by Western
blotting with the anti-Orai1 antibody. STIM1 immunoprecipitatedFig. 6. Overview of the role of lipid rafts on PM-STIM1-mediated inactivation of SOCE. PM
regulates SOCE upon store depletion preventing calcium overloading. The interaction betw
domains, which provide the environment necessary for the association between these protfrom whole platelet lysates includes both ER- and PM-located STIM1.
Our results indicate that the results obtained after STIM1 immuno-
precipitation from whole cell lysates are not solely attributed to PM-
STIM1 since the basal association with Orai1 was found to be
signiﬁcantly greater in whole cell lysates (data not shown), as well
as TG-evoked association between STIM1 and Orai1.
Despite MβCD is themost widely usedmeans to investigate the role
of lipid rafts, it should be usedwith caution since a number of problems
have been arisen associated to treatment with MβCD, including
cholesterol depletion of internal membranes, although internal mem-
branes have a lower cholesterol level than the PM, or inability to induce
complete disruption of lipid rafts due to the presence of sphingolipids in
thesemembrane domains [33].We have found that the inhibitory effect
ofMβCDon the regulation of SOCEmediated by PM-resident STIM1was
not observed when we used CLCD, thus suggesting that the effect of
MβCD was speciﬁcally mediated by cholesterol removal. Other
cholesterol scavengers, such as nystatin or ﬁlipin, as well as depletion
of sphingolipids, have been reported to induce a number of side effects
that might interfere with SOCE [44,45].
We believe that the inhibition of TG-evoked translocation of STIM1
to the PM by disruption of lipid rafts might be attributed to the
location and recruitment of STIM1 into the PM rather than to
impairment of the intracellular trafﬁcking. This is based on the lack
of effect of MβCD in the PM level of STIM1 in unstimulated cells,
which suggests that the turnover of PM-STIM1 is not altered, although
we cannot rule out the possibility of a reduced turnover. However, it
has been reported that while the recruitment of membrane proteins
in phospholipid-rich membrane regions occurs through protein-
protein interactions, proteins that associate with rafts domains
require interactions between the lipids within the rafts and the
transmembrane domain of the proteins or the lipid moiety of proteins
attached to the membrane by a lipid modiﬁcation [46]. Therefore, the
expression of raft-associated proteins in the PM requires the presence
of lipid rafts, and disruption of the raft domainsmight prevent de novo
PM association of raft-associated proteins.
In summary, here we report for the ﬁrst time that lipid raft domains
are PMplatforms required to support the interaction betweenOrai1 and
PM-resident STIM1. The latter, probably acting as a sensor of
extracellular Ca2+ concentration, is essential for the mechanism of
SOCE inactivation by extracellular Ca2+ (Fig. 6), which might be a
protective cellularmechanismtoprevent Ca2+overload and cell toxicity
and death.-resident STIM1 is associated to Orai1 and serves as an extracellular Ca2+ sensor that
een PM-resident STIM1 and Orai1 entirely depends on the integrity of the lipid raft
eins.
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